13Feb
Ahead of the pack: US M&A 2019: Biotech boosts US healthcare M&A in 2019
The healthcare sector (incorporating pharma, medical and biotech) has seen M&A valued at US$256.5 billion across 645 deals in 2019. This is a decrease of 9 percent by volume, but an increase of 121 percent by value....
By:
White & Case LLP
Related
On June 13, 2019, the U.S. Departments of Health and Human Services, Labor and the Treasury issued f...
Read More >
I admit I was among the scores of franchise lawyers whose blood pressure skyrocketed with passage of...
Read More >
On February 26, 2020, the United States Supreme Court, in a unanimous decision by Justice Samuel Ali...
Read More >
The Dechert Antitrust Merger Investigation Timing Tracker (DAMITT) is a quarterly release from Deche...
Read More >
Welcome to the Akin Gump Global Private Equity/M&A Survey 2021: Opportunities Ahead. The last 12 mo...
Read More >
The coronavirus (COVID-19) pandemic has shut down non-essential construction projects in numerous st...
Read More >